FDA 483 - AmerisourceBergen Drug Corp. - June 15, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of AmerisourceBergen Drug Corp., a warehouse distributor in Morrisville, NC, revealed significant deficiencies in its operations related to dietary supplements. The firm was cited for lacking quality control for returned supplements, failing to collect reserve samples, and not establishing written procedures for handling returned supplements, as well as for general holding and distribution activities. These observations indicate a lack of adequate controls over the firm's dietary supplement operations.
- Office
- Atlanta District Office
- Person
ID · 22f5053c-7cde-4780-a772-6a323bfda179